{"id":"W3096722156","doi":"10.1016/j.htct.2020.10.454","title":"POMALIDOMIDE, BORTEZOMIB, DEXAMETHASONE AFTER 1 PRIOR LINE OF THERAPY IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA: SUBANALYSIS OF OPTIMMISM BY AGE, PRIOR TRANSPLANT, AND HIGH-RISK CYTOGENETICS","year":2020,"lang":"en","type":"article","venue":"Hematology Transfusion and Cell Therapy","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"Hôpital Fleurimont; Centre Hospitalier Universitaire de Sherbrooke; Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Pomalidomide; Bortezomib; Medicine; Oncology; Multiple myeloma; Internal medicine; Dexamethasone; Refractory (planetary science); Lenalidomide; Cytogenetics; Biology; Chromosome","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002117739,0.0003681997,0.001318543,0.0001676129,0.00004998662,0.000005391048,0.0001038759,0.0003752995,0.0003471812],"category_scores_gemma":[0.00002374282,0.0002719417,0.0001619412,0.0003295501,0.0002618154,0.0000361197,0.00001279219,0.0003390759,0.000001218613],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003708274,"about_ca_system_score_gemma":0.00013476,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003683552,"about_ca_topic_score_gemma":0.0002363273,"domain_scores_codex":[0.9978088,0.0002437434,0.0008334961,0.0005738214,0.0002396084,0.0003005209],"domain_scores_gemma":[0.9987594,0.0003904373,0.0002453013,0.0003322986,0.00005535173,0.0002171462],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.04871,0.002142248,0.3260586,0.0006130798,0.0007778542,0.0006587696,0.008366149,0.00001628244,0.5469666,0.000006155213,0.00006660285,0.06561768],"study_design_scores_gemma":[0.09005807,0.006095936,0.0825379,0.0002408375,0.0005896614,0.0001645256,0.0003930798,0.001382436,0.8168377,0.00001753156,0.001205729,0.0004766311],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9757769,0.02218353,0.0004147179,0.000513303,0.00002985937,0.0009313648,0.000100532,0.00003036932,0.0000194995],"genre_scores_gemma":[0.8373377,0.1596604,0.002382825,0.0003865834,0.00001505148,0.00004710118,0.00004738064,0.00004667226,0.00007637717],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2698711,"threshold_uncertainty_score":0.9999733,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01803060061533693,"score_gpt":0.2509549417080469,"score_spread":0.23292434109271,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}